Henry Schein Inc

Henry Schein Inc(HSIC)の株式分析

$85.560

+0.530 (+0.62%)終値時点

Loading chart…
高値
86.250
始値
85.190
出来高加重平均価格
85.46
出来高
1.12M
時価総額
8.21B
安値
84.561
売買代金
95.38M
EV/EBITDA(TTM)
11.52

Henry Schein, Inc. is a solutions company for health care professionals. Its segments consist of Global Distribution and Value-Added Services, Global Specialty Products and Global Technology. Global Distribution and Value-Added Services include distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other practice services. This segment also markets and sells, under its own corporate brand, a portfolio of consumable merchandise. Global Specialty Products includes manufacturing, marketing and sales of dental implant and biomaterial products; endodontic, orthodontic and orthopedic products and other health care-related products and services. Global Technology includes development and distribution of practice management software, e-services, and other products.

www.henryschein.com

AI分析 of Henry Schein Inc (HSIC)

買い

Henry Schein Inc appears to be a good buy right now, with a current price of $84.01 and a forward P/E of 14.81, indicating potential undervaluation compared to its earnings growth prospects. The company reported a 6.7% revenue increase in Q2 2026, reaching $3.458 billion, and has a solid EPS guidance of $5.29 to $5.39 for the full year, reflecting strong confidence in future performance. However, the RSI is at 40.78, suggesting it is nearing oversold territory, which could indicate a buying opportunity. The main risk is the recent 5-day change of -1.02%, which shows a slight downward trend in the short term, but overall fundamentals and analyst sentiment remain strong.

アナリスト評価(16)

-10.26% 下落余地
買い
9 買い
7 中立
0 売り
現在: 85.56
安値
58.00
平均
76.78
高値
90.00

BTIG

2026-08-19

目標株価

$110

買い

Barclays

2026-08-06

目標株価

$100

オーバーウェイト

Mizuho

2026-08-05

目標株価

$86

中立

UBS

2026-08-05

目標株価

$94

中立

Barrington

2026-08-05

目標株価

$104

アウトパフォーム

バリュエーション指標

Henry Schein Inc(HSIC)の現在の予想PERは14.81で、5年平均は15.15です。

予想PER

適正
5年平均 P/E
15.15
現在のP/E
14.81
割高
16.65
割安
13.65

予想EV/EBITDA

適正
5年平均 EV/EBITDA
11.72
現在のEV/EBITDA
11.52
割高
12.45
割安
11.00

予想PSR

適正
5年平均 P/S
0.73
現在のP/S
0.67
割高
0.83
割安
0.64

Alphio AI による HSIC の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%HSIC

$82.44

シナリオ価格

基

基本

基本 · 50%HSIC

$70.37

シナリオ価格

弱

弱気

弱気 · 25%HSIC

$57.21

シナリオ価格

HSIC を保有するクジラ

B

Burgundy Asset Management Ltd.

+ を保有HSIC

+5.12%

3か月リターン

L

Lakewood Capital Management, LP

+ を保有HSIC

+3.60%

3か月リターン

E

Everett Harris & Co.

+ を保有HSIC

+3.33%

3か月リターン

S

Snyder Capital Management, L.P.

+ を保有HSIC

+3.19%

3か月リターン

S

Southpoint Capital Advisors LP

+ を保有HSIC

+3.00%

3か月リターン

S

Staley Capital Advisers, Inc.

+ を保有HSIC

+1.90%

3か月リターン

イベントタイムライン

2026-10-08 (ET)

07:30:00

Henry Schein Appoints Emmanuel Caprais as CFO

2026-09-08 (ET)

08:30:00

Applied BioCode Signs Distribution Agreement with Henry Schein

2026-08-04 (ET)

06:30:00

2026 EPS Consensus at $5.34, Revenue Growth View Raised to 4.5%-5.5%

06:30:00

Company Reports Q2 Revenue of $3.5B, Beating Expectations

2026-07-30 (ET)

07:30:00

Henry Schein Establishes Leadership Team, Restructures Executive Management

ニュース

HSIC のよくある質問 — Alphio AI が回答

Henry Schein, Inc. is a solutions company for health care professionals. Its segments consist of Global Distribution and Value-Added Services, Global Specialty Products and Global Technology. Global Distribution and Value-Added Services include distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other practice services. This segment also markets and sells, under its own corporate brand, a portfolio of consumable merchandise. Global Specialty Products includes manufacturing, marketing and sales of dental implant and biomaterial products; endodontic, orthodontic and orthopedic products and other health care-related products and services. Global Technology includes development and distribution of practice management software, e-services, and other products. It operates in the Healthcare sector (WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & S industry).

Henry Schein Inc appears to be a good buy right now, with a current price of $84.01 and a forward P/E of 14.81, indicating potential undervaluation compared to its earnings growth prospects. The company reported a 6.7% revenue increase in Q2 2026, reaching $3.458 billion, and has a solid EPS guidance of $5.29 to $5.39 for the full year, reflecting strong confidence in future performance. However, the RSI is at 40.78, suggesting it is nearing oversold territory, which could indicate a buying opportunity. The main risk is the recent 5-day change of -1.02%, which shows a slight downward trend in the short term, but overall fundamentals and analyst sentiment remain strong.

16 analysts cover HSIC: 9 rate it Buy, 7 Hold and 0 Sell. The average price target is 76.78.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める